Satellite & Industry-sponsored Symposia
Hour Location |
Title | Location |
---|---|---|
10:15 - 11:15 Carlo 1 |
Satellite Symposium MS in the 21st Century - Family involvement in MS Care: Duty or Disruption? An MS in the 21st Century Debate |
Carlo 1 |
10:15 - 10:20 |
Welcome & Introduction |
|
10:20 - 10:35 |
Debate 1: Does family involvement in consultations help to support patient engagement and understanding, or does it distract from the purpose of the appointment? |
|
10:35 - 10:50 |
Debate 2: Should communication with families be separate, recognising their need for support as well as their role as support? |
|
10:50 - 11:05 |
Debate 3: Can families have a negative influence on patient decision-making (the difference between supporting or controlling)? |
|
11:05 - 11:15 |
Q & A / Conclusion |
|
11:45 - 12:45 Carlo 3 |
Satellite Symposium Merck - The transformation of MS: from immune memory to sustained response |
Carlo 3 |
11:45 - 11:50 |
Welcome |
|
11:50 - 12:05 |
Long-term efficacy and safety of Cladribine Tablets: what do data tell us? |
|
12:05 - 12:20 |
Sustained response with Cladribine Tablets: investigating the role of immune memory cells |
|
12:20 - 12:35 |
Insights from real-world experience |
|
12:35 - 12:45 |
Q & A / Conclusion |
|
18:00 - 19:00 Carlo 3 |
Satellite Symposium Sanofi Genzyme - Treating MS: it's all about the brain! |
Carlo 3 |
18:00 - 18:15 |
Brain Atrophy in MS: it's there from the beginning |
|
18:15 - 18:30 |
Quality of Life in MS: it starts with the brain |
|
18:30 - 18:45 |
Identifying progression early on: Novel measures for better disease management |
|
18:45 - 19:00 |
Q & A / Conclusion |
Hour Location |
Title | Location |
---|---|---|
13:00 - 14:00 Carlo 3 |
Satellite Symposium Celgene - New approaches to personalised medicine in MS: Latest developments in diagnosis and monitoring |
Carlo 3 |
13:00 - 13:05 |
Welcome and introduction: The next generation |
|
13:05 - 13:20 |
New body-fluid biomarkers |
|
13:20 - 13:35 |
Early MRI diagnosis of MS: from central vein sign to chronic active lesions |
|
13:35 - 13:50 |
Are wearable devices ready to enter clinical practice? |
|
13:50 - 14:00 |
Q & A / Concluding remarks |
|
18:00 - 19:00 Carlo 3 |
Satellite Symposium Roche - Progress from T to B: the new era in MS |
Carlo 3 |
18:00 - 18:05 |
Welcome |
|
18:05 - 18:20 |
Deciphering progression in MS: common features across the disease continuum |
|
18:20 - 18:35 |
From periphery to CNS: the role of B cell: T cell interactions in MS pathophysiology |
|
18:35 - 18:50 |
Anti-CD20: a new era in treating disease progression |
|
18:50 - 19:00 |
Q & A / Concludinf Remarks |